PubRank

Eva Maria Fenyö

Author PubWeight™ 37.82‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection. N Engl J Med 2012 2.81
2 Increased survival among HIV-1 and HIV-2 dual-infected individuals compared to HIV-1 single-infected individuals. AIDS 2014 1.47
3 Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections. J Infect Dis 2010 1.40
4 Frequent CXCR4 tropism of HIV-1 subtype A and CRF02_AG during late-stage disease--indication of an evolving epidemic in West Africa. Retrovirology 2010 1.25
5 Coevolution of RANTES sensitivity and mode of CCR5 receptor use by human immunodeficiency virus type 1 of the R5 phenotype. J Virol 2004 1.17
6 Selection of human immunodeficiency virus type 1 R5 variants with augmented replicative capacity and reduced sensitivity to entry inhibitors during severe immunodeficiency. J Gen Virol 2005 1.16
7 Effect of HIV-2 infection on HIV-1 disease progression and mortality. AIDS 2014 1.08
8 Evolution of human immunodeficiency virus type 2 coreceptor usage, autologous neutralization, envelope sequence and glycosylation. J Gen Virol 2005 1.06
9 Primary HIV-1 R5 isolates from end-stage disease display enhanced viral fitness in parallel with increased gp120 net charge. Virology 2008 1.04
10 Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection. Infect Genet Evol 2009 1.01
11 HIV biological variability unveiled: frequent isolations and chimeric receptors reveal unprecedented variation of coreceptor use. AIDS 2003 1.00
12 Differential pathogenesis of primary CCR5-using human immunodeficiency virus type 1 isolates in ex vivo human lymphoid tissue. J Virol 2005 0.99
13 International network for comparison of HIV neutralization assays: the NeutNet report II. PLoS One 2012 0.99
14 Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switch. J Virol 2007 0.95
15 Link between the X4 phenotype in human immunodeficiency virus type 1-infected mothers and their children, despite the early presence of R5 in the child. J Infect Dis 2002 0.95
16 Prevalence and incidence of HIV-1 and HIV-2 before, during and after a civil war in an occupational cohort in Guinea-Bissau, West Africa. AIDS 2009 0.92
17 Potent intratype neutralizing activity distinguishes human immunodeficiency virus type 2 (HIV-2) from HIV-1. J Virol 2011 0.90
18 Inhibition of splicing by serine-arginine rich protein 55 (SRp55) causes the appearance of partially spliced HIV-1 mRNAs in the cytoplasm. Virus Res 2011 0.89
19 HIV-1 with multiple CCR5/CXCR4 chimeric receptor use is predictive of immunological failure in infected children. PLoS One 2008 0.88
20 Trends of HIV-1 and HIV-2 prevalence among pregnant women in Guinea-Bissau, West Africa: possible effect of the civil war 1998 1999. Sex Transm Infect 2007 0.85
21 Comparative studies on mucosal and intravenous transmission of simian immunodeficiency virus (SIVsm): the kinetics of evolution to neutralization resistance are related to progression rate of disease. J Gen Virol 2006 0.85
22 Serine- and arginine-rich proteins 55 and 75 (SRp55 and SRp75) induce production of HIV-1 vpr mRNA by inhibiting the 5'-splice site of exon 3. J Biol Chem 2010 0.84
23 Plaque-reduction assays for human and simian immunodeficiency virus neutralization. Methods Mol Biol 2005 0.83
24 Increased sensitivity to broadly neutralizing antibodies of end-stage disease R5 HIV-1 correlates with evolution in Env glycosylation and charge. PLoS One 2011 0.83
25 Evolution of coreceptor use and CD4-independence in envelope clones derived from SIVsm-infected macaques. Virology 2003 0.82
26 Quantitative evaluation of HIV and SIV co-receptor use with GHOST(3) cell assay. Methods Mol Biol 2005 0.82
27 Studies on toll-like receptor stimuli responsiveness in HIV-1 and HIV-2 infections. Cytokine 2009 0.82
28 High intrapatient HIV-1 evolutionary rate is associated with CCR5-to-CXCR4 coreceptor switch. Infect Genet Evol 2013 0.81
29 Comparative studies on mucosal and intravenous transmission of simian immunodeficiency virus (SIVsm): evolution of coreceptor use varies with pathogenic outcome. J Gen Virol 2006 0.80
30 Generation of neutralizing antibodies and divergence of SIVmac239 in cynomolgus macaques following short-term early antiretroviral therapy. PLoS Pathog 2010 0.80
31 Sensitivity of HIV type 1 primary isolates to human anti-CD40 antibody-mediated suppression is related to coreceptor use. AIDS Res Hum Retroviruses 2008 0.79
32 Isolation of human immunodeficiency virus-type 1 (HIV-1) clones with biological and molecular properties of the primary isolate. Virology 2006 0.79
33 Characterization of the human chemerin receptor--ChemR23/CMKLR1--as co-receptor for human and simian immunodeficiency virus infection, and identification of virus-binding receptor domains. Virology 2006 0.79
34 Biological and genetic evolution of HIV type 1 in two siblings with different patterns of disease progression. AIDS Res Hum Retroviruses 2007 0.79
35 Effect of complement on HIV-2 plasma antiviral activity is intratype specific and potent. J Virol 2012 0.78
36 Frequent intratype neutralization by plasma immunoglobulin a identified in HIV type 2 infection. AIDS Res Hum Retroviruses 2012 0.77
37 Identification of a strongly activating human anti-CD40 antibody that suppresses HIV type 1 infection. AIDS Res Hum Retroviruses 2008 0.77
38 CD4-independent use of the CCR5 receptor by sequential primary SIVsm isolates. Retrovirology 2007 0.76
39 Automated image-based assay for evaluation of HIV neutralization and cell-to-cell fusion inhibition. BMC Infect Dis 2014 0.75
40 Coreceptor usage of primary HIV type 1 isolates obtained from different lymph node subsets. AIDS Res Hum Retroviruses 2005 0.75